1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	731_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	731_QUEST_clinical_caseMIR	SENT1	-	-
3	86	86		-	-	9-11	731_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	731_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0001779_1	entidad_observable_1	17-19	731_QUEST_clinical_caseMIR	SENT1	-	-
6	edad	edad	NCFS000	C0001779_2	entidad_observable_2	20-24	731_QUEST_clinical_caseMIR	SENT1	-	-
7	en	en	SPS00	C1720294#C0332285	calificador#atributo	25-27	731_QUEST_clinical_caseMIR	SENT1	-	-
8	quien	quien	PR0CS000	-	-	28-33	731_QUEST_clinical_caseMIR	SENT1	-	-
9	se	se	P00CN000	-	-	34-36	731_QUEST_clinical_caseMIR	SENT1	-	-
10	ha	haber	VAIP3S0	-	-	37-39	731_QUEST_clinical_caseMIR	SENT1	-	-
11	detectado	detectar	VMP00SM	-	-	40-49	731_QUEST_clinical_caseMIR	SENT1	-	-
12	una	una		C0205447_1	calificador_1	50-53	731_QUEST_clinical_caseMIR	SENT1	-	-
13	fibrilación	fibrilación	NCFS000	C0004238_1	trastorno_1	54-65	731_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
14	auricular	auricular	NCMS000	C0004238_2	trastorno_2	66-75	731_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
15	no	no	RN	C1298908	calificador	76-78	731_QUEST_clinical_caseMIR	SENT1	-	-
16	valvular	valvular	AQ0CS0	-	-	79-87	731_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
17	.	.	Fp	-	-	87-88	731_QUEST_clinical_caseMIR	SENT1	-	-

1	Tiene	tener	VMIP3S0	-	-	89-94	731_QUEST_clinical_caseMIR	SENT2	-	-
2	una	una		C0205447_1	calificador_1	95-98	731_QUEST_clinical_caseMIR	SENT2	-	-
3	puntuación	puntuación	NCFS000	C0449820	atributo	99-109	731_QUEST_clinical_caseMIR	SENT2	-	-
4	CHADS2	CHADS2		-	-	110-116	731_QUEST_clinical_caseMIR	SENT2	-	-
5	de	de	SPS00	C0332285	atributo	117-119	731_QUEST_clinical_caseMIR	SENT2	-	-
6	3	3		-	-	120-121	731_QUEST_clinical_caseMIR	SENT2	-	-
7	puntos	punto	NCMP000	-	-	122-128	731_QUEST_clinical_caseMIR	SENT2	-	-
8	.	.	Fp	-	-	128-129	731_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	130-132	731_QUEST_clinical_caseMIR	SENT3	-	-
2	la	el	DA0FS0	-	-	133-135	731_QUEST_clinical_caseMIR	SENT3	-	-
3	bibliografía	bibliografía	NCFS000	-	-	136-148	731_QUEST_clinical_caseMIR	SENT3	-	-
4	,	,	Fc	-	-	148-149	731_QUEST_clinical_caseMIR	SENT3	-	-
5	pacientes	paciente	NCCP000	C0030705	persona	150-159	731_QUEST_clinical_caseMIR	SENT3	-	-
6	similares	similar	AQ0CP0	-	-	160-169	731_QUEST_clinical_caseMIR	SENT3	-	-
7	en	en	SPS00	C1720294#C0332285	calificador#atributo	170-172	731_QUEST_clinical_caseMIR	SENT3	-	-
8	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	173-184	731_QUEST_clinical_caseMIR	SENT3	-	-
9	con	con	SPS00	C0332287	atributo	185-188	731_QUEST_clinical_caseMIR	SENT3	-	-
10	Warfarina	warfarina	NCFS000	C0043031	sustancia	189-198	731_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
11	tienen	tener	VMIP3P0	-	-	199-205	731_QUEST_clinical_caseMIR	SENT3	-	-
12	un	un		C0205447_1	calificador_1	206-208	731_QUEST_clinical_caseMIR	SENT3	-	-
13	riesgo	riesgo	NCMS000	C0035647_1	calificador_1	209-215	731_QUEST_clinical_caseMIR	SENT3	-	-
14	de	de	SPS00	C0035647_2	calificador_2	216-218	731_QUEST_clinical_caseMIR	SENT3	-	-
15	ictus	ictus	NCMN000	-	-	219-224	731_QUEST_clinical_caseMIR	SENT3	-	-
16	del	del	SP+DA	-	-	225-228	731_QUEST_clinical_caseMIR	SENT3	-	-
17	2,2	2.2	Z	-	-	229-232	731_QUEST_clinical_caseMIR	SENT3	-	-
18	%	%	Ft	-	-	233-234	731_QUEST_clinical_caseMIR	SENT3	-	-
19	frente	frente	RG	C1284847#C0016540#C0549224	estructura_corporal	235-241	731_QUEST_clinical_caseMIR	SENT3	-	-
20	al	al	SP+DA	-	-	242-244	731_QUEST_clinical_caseMIR	SENT3	-	-
21	5,2	5.2	Z	-	-	245-248	731_QUEST_clinical_caseMIR	SENT3	-	-
22	%	%	Ft	-	-	249-250	731_QUEST_clinical_caseMIR	SENT3	-	-
23	en	en	SPS00	C1720294#C0332285	calificador#atributo	251-253	731_QUEST_clinical_caseMIR	SENT3	-	-
24	los	el	DA0MP0	-	-	254-257	731_QUEST_clinical_caseMIR	SENT3	-	-
25	pacientes	paciente	NCCP000	C0030705	persona	258-267	731_QUEST_clinical_caseMIR	SENT3	-	-
26	sin	sin	SPS00	C0332288	atributo	268-271	731_QUEST_clinical_caseMIR	SENT3	-	-
27	warfarina	warfarina	NCFS000	C0043031	sustancia	272-281	731_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
28	.	.	Fp	-	-	281-282	731_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	283-284	731_QUEST_clinical_caseMIR	SENT4	-	-
2	Cuál	cuál	PT0CS000	-	-	284-288	731_QUEST_clinical_caseMIR	SENT4	-	-
3	sería	ser	VSIC1S0	-	-	289-294	731_QUEST_clinical_caseMIR	SENT4	-	-
4	el	el	DA0MS0	-	-	295-297	731_QUEST_clinical_caseMIR	SENT4	-	-
5	número	número	NCMS000	C0237753#C1265611	calificador#atributo	298-304	731_QUEST_clinical_caseMIR	SENT4	-	-
6	necesario	necesario	AQ0MS0	-	-	305-314	731_QUEST_clinical_caseMIR	SENT4	-	-
7	a	a	SPS00	-	-	315-316	731_QUEST_clinical_caseMIR	SENT4	-	-
8	tratar	tratar	VMN0000	-	-	317-323	731_QUEST_clinical_caseMIR	SENT4	-	-
9	(	(	Fpa	-	-	324-325	731_QUEST_clinical_caseMIR	SENT4	-	-
10	NNT	nnt	NCMS000	-	-	325-328	731_QUEST_clinical_caseMIR	SENT4	-	-
11	)	)	Fpt	-	-	328-329	731_QUEST_clinical_caseMIR	SENT4	-	-
12	para	para	SPS00	C0521125	calificador	330-334	731_QUEST_clinical_caseMIR	SENT4	-	-
13	prevenir	prevenir	VMN0000	-	-	335-343	731_QUEST_clinical_caseMIR	SENT4	-	-
14	un	un		C0205447_1	calificador_1	344-346	731_QUEST_clinical_caseMIR	SENT4	-	-
15	ictus	ictus	NCMN000	-	-	347-352	731_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
16	embolígeno	embolígeno	NCMS000	-	-	353-363	731_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
17	con	con	SPS00	C0332287	atributo	364-367	731_QUEST_clinical_caseMIR	SENT4	-	-
18	el	el	DA0MS0	-	-	368-370	731_QUEST_clinical_caseMIR	SENT4	-	-
19	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	371-382	731_QUEST_clinical_caseMIR	SENT4	-	-
20	anticoagulante	anticoagulante	AQ0CS0	C0003280	producto#sustancia	383-397	731_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
21	?	?	Fit	-	-	397-398	731_QUEST_clinical_caseMIR	SENT4	-	-
22	:	:	Fd	-	-	398-399	731_QUEST_clinical_caseMIR	SENT4	-	-
23	.	.	Fp	-	-	399-400	731_QUEST_clinical_caseMIR	SENT4	-	-

